Lightnews — Scholar-powered news

Adolescent Medicine Trials Network @atnresearch.bsky.social · 2d

Scholars must be within 10 years of completing a terminal degree, postdoc, or first medical residency. During the program, #scholars are paired with a mentor and an ATN study and receive funding to develop a #research question and secondary analysis to conduct.

About the ATN Scholars Program
The ATN Scholars Program provides under-represented scientists with the skills, knowledge, and network to excel as independent investigators in adolescent HIV prevention.

Scholars must be within 10 years of completing a terminal degree, postdoc, or first medical residency.
The program provides funding to cover a portion of time and expenses for 18 months.
Scholars are paired with a mentor and study to develop a research question and secondary analysis to conduct.
Scholars submit at least one manuscript for publication from the mentored study and a product for dissemination to community members/participants, like an
infographic or video.

Adolescent Medicine Trials Network @atnresearch.bsky.social · 2d

Meet our new ATN scholars! 🌟 The ATN Scholars Program provides rising #researchers with the skills, knowledge, and network to excel as independent investigators in adolescent #HIVprevention.

#HIVresearch #HIV #research #science #scholars #ATNresearch #mentorship #adolescenthealth

MEET OUR NEW ATN SCHOLARS. The ATN Scholars Program provides under-represented scientists with the skills, knowledge, and network to excel as independent investigators in adolescent HIV prevention.

April Bell, PhD, MPH
University of California, San Francisco
Dr. Bell is an Assistant Professor in the Department of Family and Community Medicine (FCM) in the School of Medicine at the University of California San Francisco (UCSF). Prior to joining FCM, she was a postdoctoral scholar with the Preterm Birth Initiative at UCSF.

She obtained her PhD in Epidemiology from the Indiana University School of Public Health at Bloomington. She received her MPH with a dual concentration in Epidemiology and Social & Behavioral Sciences from the Indiana University School of Medicine and her BA in Human Biology from Stanford University.

Dr. Bell's research is focused on decreasing reproductive health inequities among women and youth by addressing the impacts of societal and structural biases on adverse birth outcomes, sexually transmitted infections, HIV acquisition, abortion access, and unintended pregnancy. Having worked extensively in both the US and across sub-Saharan Africa, she is interested in using both quantitative and qualitative methodologies, including digital storytelling, to bridge the expanse between US and African settings.

Kevon-Mark Jackman, DrPH, MPH
Johns Hopkins School of Medicine & Bloomberg School of Public Health
Dr. Kevon-Mark Jackman is an Epidemiologist and Assistant Professor
of Pediatrics at Johns Hopkins University School of Medicine, specializing in adolescent and young adult medicine.

With a DrPH and MPH his work bridges health disparities, digital health innovations, and HIV/STI prevention. He leads research funded by AHRQ and NIH, with a focus on digital health and vulnerable populations.

Juan Pablo Zapata, PhD
Northwestern University Feinberg School of Medicine
Dr. Juan Pablo Zapata is a Clinical Psychologist and Research Assistant Professor at Northwestern University (NU), where he also serves as Associate Director of the Lab for Scalable Mental Health. Before joining the NU faculty, he completed a T32 Postdoctoral Fellowship in HIV translational and implementation science, where he developed expertise in adapting interventions for diverse populations and settings.

His current research centers on scalable interventions that can be delivered digitally or by lay providers. For example, he is adapting Keep It Up! (KIU!), one of the first digital HIV prevention programs recognized by the CDC as “best evidence” into a single-session format to expand its reach, given the barriers associated with multi-session programs.

He is also adapting a lay-provider–delivered single-session intervention to support adherence among youth living with HIV, reflecting the bidirectional relationship between mental health and HIV. Dr. Zapata recently joined the LYPS ATN study, where he will contribute his expertise in developing scalable digital interventions and serve on the ATN Bioethics Subcommittee.

2 1 4

Adolescent Medicine Trials Network @atnresearch.bsky.social · 12d

Did you miss Dr. Hosek & Dr. Hightow-Weidman's presentation about the ATN for the 24 Hours to Save AIDS Research livestream event? Check out all 24 hours of presentations from around the globe here: www.youtube.com/@HIVAIDSarou...

#SaveHIVresearch #HIVresearch #HIV #HIVprevention #sexualhealth

24hrs_to_save_AIDS_research

Over the past four decades, HIV research has saved tens of millions of lives through discoveries in HIV treatment and prevention, with the US federal government playing a foundational role in that suc...

www.youtube.com

Adolescent Medicine Trials Network @atnresearch.bsky.social · Sep 8

Don’t miss Dr. Lisa Hightow-Weidman & Dr. Sybil Hosek's session!
Investing in Youth, Investing in Impact: Adolescent HIV Research in the ATN
🕗 8:40–9:00pm ET
⏰ 24 HOURS TO SAVE AIDS RESEARCH
🔗 Tune in: saveaidsresearch.org

24 Hours to Save AIDS Research

saveaidsresearch.org

1 1

Adolescent Medicine Trials Network @atnresearch.bsky.social · Sep 8

On 9/6 starting at 11am ET, join scientists, researchers, & advocates around the world spotlighting what decades of #HIV #research have achieved—and what we stand to lose. ⏰ 24 HOURS TO SAVE AIDS RESEARCH. 🔗 Tune in: saveaidsresearch.org

#SaveAIDSResearch #HIVresearch #science #adolescenthealth

1 2 2

Adolescent Medicine Trials Network @atnresearch.bsky.social · Aug 18

Follow us to stay in the loop when studies open!

#HIVresearch #adolescenthealth #getinvolved #ATNresearch

The Screen2Prevent study is using a computerized survey to find youth in pediatric emergency departments who might qualify for PrEP.

The HAPPY study completed 83% of the enrollment goal at the time of termination and has moved into the data analysis phase which will inform ATN 172, developing a novel HIV and pregnancy prevention medication.

The ATN needs YOUth participants to join us in advancing public health. A healthier future starts with you. Follow us–stay in the loop when studies open!

1

Adolescent Medicine Trials Network @atnresearch.bsky.social · Aug 18

Young people remain at the heart of everything we do, but what’s new? 👉 Swipe through to check out what’s next for the ATN.

#ATNresearch #research #science #HIVprevention #HIV #STIs

Description of the CHOOSE study, hoping to break the cycle of high rates of new HIV and STI diagnoses by testing a package of digital health tools to help young men choose which type of PrEP to take, and learning who will take doxycycline for STI prevention when offered it. Study is for young men ages 13-24 who are not living with HIV.

Description of the IMPACT study, combining evidence based talk therapy to treat depression with sexual health counseling to reduce HIV for young people who use stimulants during sexual activity.

The LYPS study aims to improve PrEP use among youth by providing PrEP services at a location outside the clinic, like a private room in a community center.

The foXXy doxy study is testing whether DoxyPEP, a common antibiotic already approved as STI prevention for men, is effective for women.

1 1

Adolescent Medicine Trials Network @atnresearch.bsky.social · Aug 18

The Adolescent Medicine Trials Network is back! ✅ Since 2001, we've been the only US research network dedicated solely to HIV prevention & care for young people—thanks to the persistence of our community, we were able to work with NIH to reinstate funding so we can continue this vital mission. 💪❤️

The ATN is back! Federal funding for our research has been reinstated.

Read our message to the community and catch up on what’s changed within our groundbreaking projects.

Since 2001, the ATN has been
the only research network in
the U.S. devoted solely to HIV
prevention and care for youth. With funding reinstated, we now continue that vital mission.

To every community member, researcher, and healthcare provider who fought tirelessly to appeal the termination of the ATN—your persistence has saved lives and livelihoods. Thank you.

To the young people and families who have trusted us with their participation in our studies—you are the heart of everything we do.

The ATN has worked with the National Institutes of Health (NIH) to maintain our commitment to our core mission of advancing research that improves the health of youth populations most impacted by HIV. What’s Updated in the ATN? We've widened the eligibility criteria for most of our studies to reach more young people who need our support. We’ve reshaped our scientific leadership groups. Check out our studies!

1 1 2

Adolescent Medicine Trials Network @atnresearch.bsky.social · Feb 6

In addition to facilitating earlier treatment among those who learn they're living w/ #HIV, the ubiquity of mobile apps & modest resources needed to scale this intervention, a 25% increase in #HIVtesting among young sexual minority men, as seen in this study, could meaningfully reduce HIV incidence.

The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled Trial - PubMed

ClinicalTrials.gov NCT03965221; https://clinicaltrials.gov/study/NCT03965221.

pubmed.ncbi.nlm.nih.gov

1 1

Adolescent Medicine Trials Network @atnresearch.bsky.social · Feb 6

NEW publication from ATN 143: COMPARE, which tested the efficacy of two apps to increase HIV testing and PrEP use among young sexual minority men.

#ATNresearch #HIVresearch #HIVtesting #PrEP #HIVprevention #digitalhealth #adolescenthealth

The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled Trial - PubMed

ClinicalTrials.gov NCT03965221; https://clinicaltrials.gov/study/NCT03965221.

pubmed.ncbi.nlm.nih.gov

1 1

Reposted by Adolescent Medicine Trials Network

Institute on Digital Health and Innovation | Florida State Univ. @idhifsu.bsky.social · Jan 15

New publication about PrEPared, Protected, emPowered (P3)! P3 engagement (dollars accrued in the app) was strongly related to lower odds of #PrEP nonadherence. More: pubmed.ncbi.nlm.nih.gov/39804696/

#ATNresearch #HIVprevention #HIVresearch #digitalhealth #adolescenthealth #sexualhealth #FSUnursing

Studying the Digital Intervention Engagement-Mediated Relationship Between Intrapersonal Measures and Pre-Exposure Prophylaxis Adherence in Sexual and Gender Minority Youth: Secondary Analysis of a Ra...

ClinicalTrials.gov; NCT03320512; https://clinicaltrials.gov/study/NCT03320512.

pubmed.ncbi.nlm.nih.gov

1 2